{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:38:18Z","timestamp":1791315498876,"version":"4.3.1"},"reference-count":103,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Cardiovascular diseases (CVDs) have become the leading cause of death globally, surpassing infectious diseases and other chronic illnesses. The incidence and mortality rates of CVDs are rising worldwide, posing a key challenge in public health. The ubiquitination system is a vast and complex. It is an important post-translational modification that plays a crucial role in various cellular processes. Deubiquitination is catalyzed by deubiquitinases (DUBs), which remove ubiquitin (Ub) from ubiquitinated proteins, thereby reversing the ubiquitination process. DUBs play an important role in many biological processes, such as DNA repair, cell metabolism, differentiation, epigenetic regulation, and protein stability control. They also participate in the regulation of many signaling pathways associated with the development and progression of CVDs. In this review, we primarily focus on the role of DUBs in various key pathological mechanisms of atherosclerosis (AS), such as foam cell formation, vascular remodeling (VR), endothelial-to-mesenchymal transition (End-MT), and clonal hematopoiesis (CH). In the heart, we summarize the involvement of DUBs in diseases and pathological processes, including heart failure (HF), myocardial infarction (MI), myocardial hypertrophy (MH) and ischemia\/reperfusion (I\/R) injury. Additionally, we also explore the diabetic cardiomyopathy (DCM) and the use of doxorubicin-induced cardiotoxicity in clinical settings. A comprehensive understanding of deubiquitination may provide new insights for the treatment and drug design of CVDs.<\/jats:p>","DOI":"10.3389\/fcvm.2025.1582049","type":"journal-article","created":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T01:39:45Z","timestamp":1746063585000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["The role of deubiquitinases in cardiovascular diseases: mechanisms and therapeutic implications"],"prefix":"10.3389","volume":"12","author":[{"given":"Xiangyu","family":"Fei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyong","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huifang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41569-018-0119-4","article-title":"Epidemiology of cardiovascular disease in China: current features and implications","volume":"16","author":"Zhao","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1152\/physrev.00027.2001","article-title":"The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction","volume":"82","author":"Glickman","year":"2002","journal-title":"Physiol Rev"},{"key":"B3","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1146\/annurev.biochem.67.1.425","article-title":"The ubiquitin system","volume":"67","author":"Hershko","year":"1998","journal-title":"Annu Rev Biochem"},{"key":"B4","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/cr.2016.39","article-title":"Ubiquitin modifications","volume":"26","author":"Swatek","year":"2016","journal-title":"Cell Res"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.7150\/ijbs.69411","article-title":"The role of ubiquitination and deubiquitination in tumor invasion and metastasis","volume":"18","author":"Han","year":"2022","journal-title":"Int J Biol Sci"},{"key":"B6","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/nrm2731","article-title":"Breaking the chains: structure and function of the deubiquitinases","volume":"10","author":"Komander","year":"2009","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41580-019-0099-1","article-title":"Breaking the chains: deubiquitylating enzyme specificity begets function","volume":"20","author":"Clague","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.trecan.2019.08.005","article-title":"DUBs, hypoxia, and cancer","volume":"5","author":"Mennerich","year":"2019","journal-title":"Trends Cancer"},{"key":"B9","doi-asserted-by":"publisher","first-page":"986","DOI":"10.3390\/IJMS22030986","article-title":"Molecular mechanisms of DUBs regulation in signaling and disease","volume":"22","author":"Li","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.molcel.2021.10.027","article-title":"Deubiquitinases: from mechanisms to their inhibition by small molecules","volume":"82","author":"Lange","year":"2022","journal-title":"Mol Cell"},{"key":"B11","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1007\/s13238-017-0486-3","article-title":"The role of ubiquitination and deubiquitination in the regulation of cell junctions","volume":"9","author":"Cai","year":"2018","journal-title":"Protein Cell"},{"key":"B12","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nrm3099","article-title":"The spatial and temporal organization of ubiquitin networks","volume":"12","author":"Grabbe","year":"2011","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"C7","DOI":"10.1016\/j.jacc.2005.09.068","article-title":"Pathogenesis of atherosclerosis","volume":"47","author":"Falk","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/s41419-024-07166-8","article-title":"Inflammation in atherosclerosis: pathophysiology and mechanisms","volume":"15","author":"Ajoolabady","year":"2024","journal-title":"Cell Death Dis"},{"key":"B15","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41586-021-03392-8","article-title":"The changing landscape of atherosclerosis","volume":"592","author":"Libby","year":"2021","journal-title":"Nature"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms242015160","article-title":"New dawn for atherosclerosis: vascular endothelial cell senescence and death","volume":"24","author":"Bu","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1093\/cvr\/cvad076","article-title":"Endothelial mechanobiology in atherosclerosis","volume":"119","author":"Wang","year":"2023","journal-title":"Cardiovasc Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"114198","DOI":"10.1016\/j.biopha.2022.114198","article-title":"Effects of shear stress on vascular endothelial functions in atherosclerosis and potential therapeutic approaches","volume":"158","author":"Cheng","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1039241","DOI":"10.3389\/fimmu.2022.1039241","article-title":"ROS-triggered endothelial cell death mechanisms: focus on pyroptosis, parthanatos, and ferroptosis","volume":"13","author":"Zheng","year":"2022","journal-title":"Front Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"159258","DOI":"10.1016\/j.bbalip.2022.159258","article-title":"USP14-mediated NLRC5 upregulation inhibits endothelial cell activation and inflammation in atherosclerosis","volume":"1868","author":"Fu","year":"2023","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"B21","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s10020-024-00798-8","article-title":"USF1 Transcriptionally activates USP14 to drive atherosclerosis by promoting EndMT through NLRC5\/Smad2\/3 axis","volume":"30","author":"Zhang","year":"2024","journal-title":"Mol Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.canlet.2019.03.005","article-title":"NLRC5: a paradigm for NLRs in immunological and inflammatory reaction","volume":"451","author":"Wu","year":"2019","journal-title":"Cancer Lett"},{"key":"B23","doi-asserted-by":"publisher","first-page":"103318","DOI":"10.1016\/j.redox.2024.103318","article-title":"ALDH2 Deficiency augments atherosclerosis through the USP14-cGAS-dependent polarization of proinflammatory macrophages","volume":"76","author":"Rui","year":"2024","journal-title":"Redox Biol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s11010-017-2978-0","article-title":"Ubiquitin-specific protease 14 regulates LPS-induced inflammation by increasing ERK1\/2 phosphorylation and NF-\u03baB activation","volume":"431","author":"Liu","year":"2017","journal-title":"Mol Cell Biochem"},{"key":"B25","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.trsl.2024.04.002","article-title":"Inhibition of Usp14 ameliorates renal ischemia-reperfusion injury by reducing Tfap2a stabilization and facilitating mitophagy","volume":"270","author":"Li","year":"2024","journal-title":"Transl Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"6213","DOI":"10.3390\/ijms22126213","article-title":"Small-Molecule inhibitors targeting proteasome-associated deubiquitinases","volume":"22","author":"Moon","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1161\/ATVBAHA.121.313788","article-title":"Endothelial-mesenchymal transition in cardiovascular disease","volume":"41","author":"Alvandi","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e56135","DOI":"10.15252\/embr.202256135","article-title":"Mouse endothelial OTUD1 promotes angiotensin II-induced vascular remodeling by deubiquitinating SMAD3","volume":"24","author":"Huang","year":"2023","journal-title":"EMBO Rep"},{"key":"B29","doi-asserted-by":"publisher","first-page":"102207","DOI":"10.1016\/j.coph.2022.102207","article-title":"Smad-dependent pathways in the infarcted and failing heart","volume":"64","author":"Humeres","year":"2022","journal-title":"Curr Opin Pharmacol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1161\/HYPERTENSIONAHA.110.150466","article-title":"Is Smad3 the key to inflammation and fibrosis in hypertensive heart disease?","volume":"55","author":"Graf","year":"2010","journal-title":"Hypertension"},{"key":"B31","doi-asserted-by":"publisher","first-page":"154849","DOI":"10.1016\/j.phymed.2023.154849","article-title":"Dengzhan Shengmai capsule attenuates cardiac fibrosis in post-myocardial infarction rats by regulating LTBP2 and TGF-\u03b21\/Smad3 pathway","volume":"116","author":"Wang","year":"2023","journal-title":"Phytomedicine"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1101\/gad.1350705","article-title":"Smad transcription factors","volume":"19","author":"Massagu\u00e9","year":"2005","journal-title":"Genes Dev"},{"key":"B33","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/s41569-022-00718-5","article-title":"Non-canonical WNT signalling in cardiovascular disease: mechanisms and therapeutic implications","volume":"19","author":"Akoumianakis","year":"2022","journal-title":"Nat Rev Cardiol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/s41569-023-00845-7","article-title":"Calcific aortic valve disease: mechanisms, prevention and treatment","volume":"20","author":"Moncla","year":"2023","journal-title":"Nat Rev Cardiol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"925923","DOI":"10.3389\/fcvm.2022.925923","article-title":"Mechanisms of oxidized LDL-mediated endothelial dysfunction and its consequences for the development of atherosclerosis","volume":"9","author":"Jiang","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1161\/ATVBAHA.108.176644","article-title":"Loss of SR-A and CD36 activity reduces atherosclerotic lesion complexity without abrogating foam cell formation in hyperlipidemic mice","volume":"29","author":"Manning-Tobin","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1016\/j.jacc.2006.01.073","article-title":"Increased activity of the ubiquitin-proteasome system in patients with symptomatic carotid disease is associated with enhanced inflammation and may destabilize the atherosclerotic plaque","volume":"47","author":"Marfella","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/JCI154217","article-title":"Disruption of USP9X in macrophages promotes foam cell formation and atherosclerosis","volume":"132","author":"Wang","year":"2022","journal-title":"J Clin Invest"},{"key":"B39","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.1111\/jcmm.15002","article-title":"Inhibition of USP14 suppresses the formation of foam cell by promoting CD36 degradation","volume":"24","author":"Zhang","year":"2020","journal-title":"J Cell Mol Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.7150\/ijbs.91957","article-title":"Endothelial dickkopf-1 promotes smooth muscle cell-derived foam cell formation via USP53-mediated deubiquitination of SR-A during atherosclerosis","volume":"20","author":"Liu","year":"2024","journal-title":"Int J Biol Sci"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1185587","DOI":"10.3389\/fimmu.2023.1185587","article-title":"Macrophage polarization states in atherosclerosis","volume":"14","author":"Wu","year":"2023","journal-title":"Front Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"113603","DOI":"10.1016\/j.fct.2023.113603","article-title":"Cadmium contributes to atherosclerosis by affecting macrophage polarization","volume":"173","author":"Wan","year":"2023","journal-title":"Food Chem Toxicol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/s41419-023-06206-z","article-title":"Macrophage polarization and metabolism in atherosclerosis","volume":"14","author":"Hou","year":"2023","journal-title":"Cell Death Dis"},{"key":"B44","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1007\/s11033-018-4405-3","article-title":"Deubiquitinase Mysm1 regulates macrophage survival and polarization","volume":"45","author":"Zhao","year":"2018","journal-title":"Mol Biol Rep"},{"key":"B45","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1093\/ajh\/hpaa195","article-title":"Mechanisms of vascular remodeling in hypertension","volume":"34","author":"Humphrey","year":"2021","journal-title":"Am J Hypertens"},{"key":"B46","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1161\/CIRCRESAHA.115.306361","article-title":"Vascular smooth muscle cells in atherosclerosis","volume":"118","author":"Bennett","year":"2016","journal-title":"Circ Res"},{"key":"B47","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1042\/bj3570617","article-title":"Isolation and characterization of two novel A20-like proteins","volume":"357","author":"Evans","year":"2001","journal-title":"Biochem J"},{"key":"B48","doi-asserted-by":"publisher","first-page":"7036","DOI":"10.1074\/jbc.M708690200","article-title":"NF-kappaB suppression by the deubiquitinating enzyme Cezanne: a novel negative feedback loop in pro-inflammatory signaling","volume":"283","author":"Enesa","year":"2008","journal-title":"J Biol Chem"},{"key":"B49","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1093\/cvr\/cvab056","article-title":"Cezanne is a critical regulator of pathological arterial remodelling by targeting \u03b2-catenin signalling","volume":"118","author":"An","year":"2022","journal-title":"Cardiovasc Res"},{"key":"B50","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41392-021-00762-6","article-title":"Wnt\/\u03b2-catenin signalling: function, biological mechanisms, and therapeutic opportunities","volume":"7","author":"Liu","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"B51","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13045-024-01563-4","article-title":"Wnt\/\u03b2-catenin signaling pathway in carcinogenesis and cancer therapy","volume":"17","author":"Song","year":"2024","journal-title":"J Hematol Oncol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.cbpa.2021.02.009","article-title":"Intrinsically disordered proteins and biomolecular condensates as drug targets","volume":"62","author":"Biesaga","year":"2021","journal-title":"Curr Opin Chem Biol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"101258","DOI":"10.1016\/j.jbc.2021.101258","article-title":"USP10 Exacerbates neointima formation by stabilizing Skp2 protein in vascular smooth muscle cells","volume":"297","author":"Xia","year":"2021","journal-title":"J Biol Chem"},{"key":"B54","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41420-024-02069-1","article-title":"USP14 Deficiency inhibits neointima formation following vascular injury via degradation of Skp2 protein","volume":"10","author":"Xia","year":"2024","journal-title":"Cell Death Discov"},{"key":"B55","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1001\/jamacardio.2018.3965","article-title":"Association of mutations contributing to clonal hematopoiesis with prognosis in chronic ischemic heart failure","volume":"4","author":"Dorsheimer","year":"2019","journal-title":"JAMA Cardiol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"4673","DOI":"10.1126\/science.aan4673","article-title":"Clonal hematopoiesis in human aging and disease","volume":"366","author":"Jaiswal","year":"2019","journal-title":"Science"},{"key":"B57","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1701719","article-title":"Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease","volume":"377","author":"Jaiswal","year":"2017","journal-title":"N Engl J Med"},{"key":"B58","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1161\/CIRCRESAHA.117.312115","article-title":"Somatic mutations and clonal hematopoiesis","volume":"122","author":"Fuster","year":"2018","journal-title":"Circ Res"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1161\/CIRCULATIONAHA.123.065344","article-title":"BRCC3-mediated NLRP3 deubiquitylation promotes inflammasome activation and atherosclerosis in Tet2 clonal hematopoiesis","volume":"148","author":"Yalcinkaya","year":"2023","journal-title":"Circulation"},{"key":"B60","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nm.3806","article-title":"A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat Med"},{"key":"B61","doi-asserted-by":"publisher","first-page":"19305","DOI":"10.1038\/s41598-021-98437-3","article-title":"The selective NLRP3 inhibitor MCC950 hinders atherosclerosis development by attenuating inflammation and pyroptosis in macrophages","volume":"11","author":"Zeng","year":"2021","journal-title":"Sci Rep"},{"key":"B62","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.phrs.2019.01.035","article-title":"NLRP3 Inflammasome inhibition with MCC950 improves diabetes-mediated cognitive impairment and vasoneuronal remodeling after ischemia","volume":"142","author":"Ward","year":"2019","journal-title":"Pharmacol Res"},{"key":"B63","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.bbi.2023.11.031","article-title":"MCC950 Reduces autophagy and improves cognitive function by inhibiting NLRP3-dependent neuroinflammation in a rat model of Alzheimer\u2019s disease","volume":"116","author":"Naeem","year":"2024","journal-title":"Brain Behav Immun"},{"key":"B64","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","article-title":"Mechanisms of physiological and pathological cardiac hypertrophy","volume":"15","author":"Nakamura","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.freeradbiomed.2022.01.020","article-title":"Elabela alleviates ferroptosis, myocardial remodeling, fibrosis and heart dysfunction in hypertensive mice by modulating the IL-6\/STAT3\/GPX4 signaling","volume":"181","author":"Zhang","year":"2022","journal-title":"Free Radic Biol Med"},{"key":"B66","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1242\/dev.132910","article-title":"Building and re-building the heart by cardiomyocyte proliferation","volume":"143","author":"Foglia","year":"2016","journal-title":"Development"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1016\/j.cellsig.2010.06.002","article-title":"Effect of pressure overload-induced hypertrophy on the expression and localization of p38 MAP kinase isoforms in the mouse heart","volume":"22","author":"Dingar","year":"2010","journal-title":"Cell Signal"},{"key":"B68","doi-asserted-by":"publisher","first-page":"H46","DOI":"10.1152\/ajpheart.00597.2016","article-title":"MK5 Haplodeficiency attenuates hypertrophy and preserves diastolic function during remodeling induced by chronic pressure overload in the mouse heart","volume":"313","author":"Nawaito","year":"2017","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1042\/BST20130012","article-title":"Epigenetics in the heart: the role of histone modifications in cardiac remodelling","volume":"41","author":"Tingare","year":"2013","journal-title":"Biochem Soc Trans"},{"key":"B70","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s10741-019-09873-3","article-title":"SERCA2a: a key protein in the Ca(2+) cycle of the heart failure","volume":"25","author":"Zhihao","year":"2020","journal-title":"Heart Fail Rev"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejphar.2013.12.018","article-title":"Cardiac SERCA2A\/B: therapeutic targets for heart failure","volume":"724","author":"Shareef","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1161\/CIRCRESAHA.122.321849","article-title":"USP25 Ameliorates pathological cardiac hypertrophy by stabilizing SERCA2a in cardiomyocytes","volume":"132","author":"Ye","year":"2023","journal-title":"Circ Res"},{"key":"B73","doi-asserted-by":"publisher","first-page":"167061","DOI":"10.1016\/j.bbadis.2024.167061","article-title":"Deubiquitinase OTUD6a drives cardiac inflammation and hypertrophy by deubiquitination of STING","volume":"1870","author":"Fang","year":"2024","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B74","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1016\/j.jacc.2007.09.011","article-title":"Universal definition of myocardial infarction","volume":"50","author":"Thygesen","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"167018","DOI":"10.1016\/j.bbadis.2024.167018","article-title":"OTUD1 Promotes isoprenaline- and myocardial infarction-induced heart failure by targeting PDE5A in cardiomyocytes","volume":"1870","author":"Wang","year":"2024","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1111\/bph.12959","article-title":"The cGMP\/PKG pathway as a common mediator of cardioprotection: translatability and mechanism","volume":"172","author":"Inserte","year":"2015","journal-title":"Br J Pharmacol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1161\/CIRCRESAHA.107.162511","article-title":"Phosphodiesterase type 5","volume":"101","author":"Kass","year":"2007","journal-title":"Circ Res"},{"key":"B78","doi-asserted-by":"publisher","first-page":"106077","DOI":"10.1016\/j.phrs.2022.106077","article-title":"Main active components of Si-Miao-Yong-An decoction (SMYAD) attenuate autophagy and apoptosis via the PDE5A-AKT and TLR4-NOX4 pathways in isoproterenol (ISO)-induced heart failure models","volume":"176","author":"Liao","year":"2022","journal-title":"Pharmacol Res"},{"key":"B79","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.yjmcc.2003.11.001","article-title":"Cardioprotection with phosphodiesterase-5 inhibition\u2013a novel preconditioning strategy","volume":"36","author":"Kukreja","year":"2004","journal-title":"J Mol Cell Cardiol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.7150\/thno.83340","article-title":"OTUD1 Promotes pathological cardiac remodeling and heart failure by targeting STAT3 in cardiomyocytes","volume":"13","author":"Wang","year":"2023","journal-title":"Theranostics"},{"key":"B81","doi-asserted-by":"publisher","first-page":"e2301852","DOI":"10.1002\/advs.202301852","article-title":"Deubiquitinase OTUD5 as a novel protector against 4-HNE-triggered ferroptosis in myocardial ischemia\/reperfusion injury","volume":"10","author":"Liu","year":"2023","journal-title":"Adv Sci"},{"key":"B82","doi-asserted-by":"publisher","first-page":"721795","DOI":"10.3389\/fcell.2021.721795","article-title":"4-Hydroxy-2-nonenal promotes cardiomyocyte necroptosis via stabilizing receptor-interacting serine\/threonine-protein kinase 1","volume":"9","author":"Zhai","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3109\/10715762.2013.864761","article-title":"Regulation and therapeutic strategies of 4-hydroxy-2-nonenal metabolism in heart disease","volume":"48","author":"Mali","year":"2014","journal-title":"Free Radic Res"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1152\/physrev.00022.2018","article-title":"Fundamental mechanisms of regulated cell death and implications for heart disease","volume":"99","author":"Del Re","year":"2019","journal-title":"Physiol Rev"},{"key":"B85","first-page":"640","article-title":"Cardiomyopathy: an overview","volume":"96","author":"Brieler","year":"2017","journal-title":"Am Fam Physician"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1161\/CIRCRESAHA.122.319835","article-title":"Arrhythmias as presentation of genetic cardiomyopathy","volume":"130","author":"Lukas Laws","year":"2022","journal-title":"Circ Res"},{"key":"B87","doi-asserted-by":"publisher","first-page":"3267","DOI":"10.2174\/092986709788803312","article-title":"Doxorubicin: the good, the bad and the ugly effect","volume":"16","author":"Carvalho","year":"2009","journal-title":"Curr Med Chem"},{"key":"B88","doi-asserted-by":"publisher","first-page":"110937","DOI":"10.1016\/j.cellsig.2023.110937","article-title":"Deubiquitinase OTUB1 regulates doxorubicin-induced cardiotoxicity via deubiquitinating c-MYC","volume":"113","author":"Xu","year":"2024","journal-title":"Cell Signal"},{"key":"B89","doi-asserted-by":"publisher","first-page":"111070","DOI":"10.1016\/j.cellsig.2024.111070","article-title":"USP36-mediated PARP1 deubiquitination in doxorubicin-induced cardiomyopathy","volume":"117","author":"Wang","year":"2024","journal-title":"Cell Signal"},{"key":"B90","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.freeradbiomed.2024.10.302","article-title":"USP14 Modulates cell pyroptosis and ameliorates doxorubicin-induced cardiotoxicity by deubiquitinating and stabilizing SIRT3","volume":"225","author":"Zhang","year":"2024","journal-title":"Free Radic Biol Med"},{"key":"B91","doi-asserted-by":"publisher","first-page":"153426","DOI":"10.1016\/j.tox.2023.153426","article-title":"Protective role of cezanne in doxorubicin-induced cardiotoxicity by inhibiting autophagy, apoptosis and oxidative stress","volume":"485","author":"Zhang","year":"2023","journal-title":"Toxicology"},{"key":"B92","doi-asserted-by":"publisher","first-page":"760","DOI":"10.7150\/ijbs.65258","article-title":"Underlying the mechanisms of doxorubicin-induced acute cardiotoxicity: oxidative stress and cell death","volume":"18","author":"Kong","year":"2022","journal-title":"Int J Biol Sci"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1161\/CIRCRESAHA.118.314665","article-title":"Diabetic cardiomyopathy","volume":"124","author":"Dillmann","year":"2019","journal-title":"Circ Res"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms242015376","article-title":"Ubiquitin proteasome system role in diabetes-induced cardiomyopathy","volume":"24","author":"Nahum-Ankonina","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B95","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1161\/CIRCULATIONAHA.123.065603","article-title":"USP28 serves as a key suppressor of mitochondrial morphofunctional defects and cardiac dysfunction in the diabetic heart","volume":"149","author":"Xie","year":"2024","journal-title":"Circulation"},{"key":"B96","doi-asserted-by":"publisher","first-page":"758158","DOI":"10.3389\/fcvm.2021.758158","article-title":"Activated protein C ameliorates diabetic cardiomyopathy via modulating OTUB1\/YB-1\/MEF2B axis","volume":"8","author":"Zhong","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B97","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.1182\/blood-2017-05-782102","article-title":"Cytoprotective activated protein C averts Nlrp3 inflammasome-induced ischemia-reperfusion injury via mTORC1 inhibition","volume":"130","author":"Nazir","year":"2017","journal-title":"Blood"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/sciadv.abe3706","article-title":"Nitric oxide prevents aortic valve calcification by S-nitrosylation of USP9X to activate NOTCH signaling","volume":"7","author":"Majumdar","year":"2021","journal-title":"Sci Adv"},{"key":"B99","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.molcel.2012.11.009","article-title":"Deubiquitination of NLRP3 by BRCC3 critically regulates inflammasome activity","volume":"49","author":"Py","year":"2013","journal-title":"Mol Cell"},{"key":"B100","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1038\/s41401-024-01278-9","article-title":"Endothelial deubiquinatase YOD1 mediates ang II-induced vascular endothelial-mesenchymal transition and remodeling by regulating \u03b2-catenin","volume":"45","author":"Lin","year":"2024","journal-title":"Acta Pharmacol Sin"},{"key":"B101","doi-asserted-by":"publisher","first-page":"e2303807","DOI":"10.1002\/advs.202303807","article-title":"Deubiquitylating enzymes in cancer and immunity","volume":"10","author":"Ren","year":"2023","journal-title":"Adv Sci"},{"key":"B102","doi-asserted-by":"publisher","first-page":"13166","DOI":"10.1038\/ncomms13166","article-title":"Targeted inhibition of the COP9 signalosome for treatment of cancer","volume":"7","author":"Schlierf","year":"2016","journal-title":"Nat Commun"},{"key":"B103","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1016\/j.chembiol.2011.08.014","article-title":"Selective and cell-active inhibitors of the USP1 UAF1 deubiquitinase complex reverse cisplatin resistance in non-small cell lung cancer cells","volume":"18","author":"Chen","year":"2011","journal-title":"Chem Biol"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1582049\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T01:39:46Z","timestamp":1746063586000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1582049\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,1]]},"references-count":103,"alternative-id":["10.3389\/fcvm.2025.1582049"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2025.1582049","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,1]]},"article-number":"1582049"}}